Status:
COMPLETED
Evaluation of Clinical Decision Support System-mPDia for Neurodegenerative Parkinsonism Using MRI Images
Lead Sponsor:
Heuron Inc.
Conditions:
Diagnoses Disease
Eligibility:
All Genders
19+ years
Brief Summary
mPDia is a software that has been pre-learned based on a neurodegenerative parkinsonism diagnosis model using Nigrosome 1 MRI images, and clinical decision support system for diagnosing neurodegenerat...
Eligibility Criteria
Inclusion
- Inclusion Criteria(Normal cohort):
- Adults over 19 years old
- 3T nigrosome 1 MRI acquired
- 18F FP-CIT PET/CT are confirmed to be normal
- The person who visits parkinsonism symptoms but is not or is normal for neurodegenerative parkinsonism
- Inclusion Criteria(Abnormal cohort):
- Adults over 19 years old
- 3T nigrosome 1 MRI acquired
- 18F FP-CIT PET/CT are confirmed to be abnormal
- The person who visits parkinsonism symptoms and has been diagnosed with neurodegenerative parkinsonism
- Exclusion Criteria:
- Patients with other brain diseases except parkinsonism
- Who have anatomical abnormality in MRIs etc.
- Who have other causes of tremor(e.g., thyroid disease)
- Patients with lesion in basal ganglia(e.g., vascular parkinsonism, hydrocephalus and Wilson's disease)
Exclusion
Key Trial Info
Start Date :
March 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
221 Patients enrolled
Trial Details
Trial ID
NCT04334902
Start Date
March 13 2020
End Date
October 30 2020
Last Update
October 29 2025
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Cha Medical Center
Gyeonggi-do, South Korea
2
Hallym University Dongtan Sacred Heart Hospital
Gyeonggi-do, South Korea
3
Hallym University Sacred Heart Hospital
Gyeonggi-do, South Korea
4
Korea University Ansan Hospital
Gyeonggi-do, South Korea